Vaccine Therapy for Unresectable Chordoma
In this phase II clinical trial, adult patients with inoperable chordoma who are scheduled to undergo radiation therapy will be randomly assigned to receive a yeast-based vaccine that targets a protein called brachyury or a placebo injection.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1041767.htm
- Syndication ID: 19856
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:16 PM
- Date Syndication Updated: Sunday, June 21, 2020 at 06:20 AM
Tags
General:
vaccine
malignant mesothelioma
immunotherapy
chordoma
Embed Code Snippet
To get the embed code snippet please Login.
